This compound is primarily used as a building block in organic synthesis, particularly in the pharmaceutical industry. It serves as a key intermediate in the development of various drugs, especially those targeting neurological disorders and cancer. Its boronic acid group enables it to participate in Suzuki-Miyaura cross-coupling reactions, which are widely employed to form carbon-carbon bonds in the synthesis of complex molecules. Additionally, its fluorine and pyran moieties contribute to enhancing the bioavailability and metabolic stability of the final drug candidates. Researchers also utilize it in the design of enzyme inhibitors and receptor modulators due to its structural versatility.